Economics at your fingertips  

PharmacoEconomics - Open

2017 - 2017

Current editor(s): Timothy Wrightson and Christopher Carswell

From Springer
Series data maintained by Sonal Shukla ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 1, issue 3, 2017

Can Price Transparency Contribute to More Affordable Patient Access to Medicines? pp. 145-147 Downloads
Sabine Vogler and Kenneth R. Paterson
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review pp. 149-165 Downloads
Spyros Kolovos, Judith E. Bosmans, Heleen Riper, Karine Chevreul, Veerle M. H. Coupé and Maurits W. Tulder
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology pp. 167-173 Downloads
Kavisha Jayasundara, Murray Krahn, Muhammad Mamdani, Jeffrey S. Hoch and Paul Grootendorst
Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial pp. 175-184 Downloads
Abualbishr Alshreef, Allan J. Wailoo, Steven R. Brown, James P. Tiernan, Angus J. M. Watson, Katie Biggs, Mike Bradburn and Daniel Hind
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications pp. 185-194 Downloads
Charles C. Ezenduka, Daniel Resende Falleiros and Brian B. Godman
Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib pp. 195-202 Downloads
Jörg Mahlich, Shinichiro Okamoto and Akiko Tsubota
Health System Efficiency: A Fragmented Picture Based on OECD Data pp. 203-221 Downloads
Andreas Behr and Katja Theune
Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study pp. 223-229 Downloads
Astrid Darsonval, Virginie Besson and Claire Cavalin

Volume 1, issue 2, 2017

Model Registration: A Call to Action pp. 73-77 Downloads
Christopher Sampson and Tim Wrightson
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations pp. 79-97 Downloads
Andrea Gabrio, Alexina J. Mason and Gianluca Baio
Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process pp. 99-108 Downloads
Eva Kaltenthaler, Christopher Carroll, Daniel Hill-McManus, Alison Scope, Michael Holmes, Stephen Rice, Micah Rose, Paul Tappenden and Nerys Woolacott
A Comparison of Inpatient Cost Per Day in General Surgery Patients with Type 2 Diabetes Treated with Basal-Bolus versus Sliding Scale Insulin Regimens pp. 109-115 Downloads
Victoria L. Phillips, Anwar L. Byrd, Saira Adeel, Limin Peng, Dawn D. Smiley and Guillermo E. Umpierrez
Cost-Benefit Analysis of Telemedicine Systems/Units in Greek Remote Areas pp. 117-121 Downloads
Marios-Nikolaos Kouskoukis and Charalambos Botsaris
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015 pp. 123-131 Downloads
Ziyad S. Almalki, Xiaomeng Yue, Ying Xia, Patricia R. Wigle and Jeff Jianfei Guo
Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes pp. 133-141 Downloads
Christoffer Lilja Terjesen, Julia Kovaleva and Lars Ehlers
Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations pp. 143-143 Downloads
Andrea Gabrio, Alexina J. Mason and Gianluca Baio

Volume 1, issue 1, 2017

The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review pp. 1-12 Downloads
Blythe Adamson, Dobromir Dimitrov, Beth Devine and Ruanne Barnabas
Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey pp. 13-23 Downloads
Jeff Richardson, Angelo Iezzi, Gang Chen and Aimee Maxwell
Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK pp. 25-36 Downloads
Jameel Nazir, Malin Berling, Charles McCrea, Francis Fatoye, Sally Bowditch, Zalmai Hakimi and Adrian Wagg
Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model pp. 37-51 Downloads
Barbara Graaff, Lei Si, Amanda L. Neil, Kwang Chien Yee, Kristy Sanderson, Lyle C. Gurrin and Andrew J. Palmer
A Single-Center Cost Analysis of Treating Primary and Metastatic Brain Cancers with Either Brain Laser Interstitial Thermal Therapy (LITT) or Craniotomy pp. 53-63 Downloads
Eric C. Leuthardt, Jeff Voigt, Albert H. Kim and Pete Sylvester
Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review pp. 65-68 Downloads
Ilke Akpinar, Philip Jacobs and Tien Dat Tran
Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review” pp. 69-70 Downloads
Przemysław Holko
Authors’ Reply to Holko: “Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review” pp. 71-71 Downloads
Ilke Akpinar, Philip Jacobs and Dat T. Tran
Page updated 2017-10-13